S&P/ASX All Ords Index (ASX: XAO) shares are down 1.6% to 8,961.6 points on Thursday.

Meanwhile, on The Bull, three experts give us their views on three ASX All Ords shares.

Let’s check them out. 

Saluda Medical Inc (ASX: SLD)

The Saluda Medical share price is 40 cents, down 3.7% today and down 69% over 12 months. 

Stuart Bromley from Medallion Financial Group has a buy call on this ASX All Ords healthcare share. 

Bromley said: 

Saluda makes the Evoke spinal cord stimulator, which automatically adjusts pain therapy in real time.

Results in full year 2026 were strong, in our view. Revenue of $US90.2 million was up 28 per cent on the prior corresponding period and ahead of upgraded guidance. US patient implants increased by 50 per cent in the fourth quarter of 2026.

With its newly approved CAP24 surgical paddle lead expanding the addressable US market by about 30 per cent, we believe SLD presents as an attractive buying opportunity for investors comfortable with potential share price volatility and risk.

Generation Development Group Ltd (ASX: GDG)

The Generation Development share price is $3.12, down 2.5% today and down 51% over 12 months. 

Bromley has a hold rating on this ASX 200 financial share.  

He said: 

GDG operates a portfolio of growing financial services businesses, including Generation Life, Evidentia Group and Lonsec.

Total revenue of $178.7 million in full year 2026 was up 23 per cent on the prior corresponding period.

Underlying net profit after tax of $40.7 million grew 21 per cent, supported by growth of 37 per cent in funds under management and record group net inflows of $9.7 billion.

We believe GDG’s longer term growth opportunity remains intact.

Fletcher Building Ltd (ASX: FBU)

The Fletcher Building share price is $3.04, down 2.3% today and up 9% over 12 months. 

Mark Elzayed from Vestra Capital has a sell rating on this ASX 200 industrials share. 

Elzayed said: 

The return to profitability reflected a combination of cost reductions, portfolio simplification, property sale gains and an improved performance across several core manufacturing businesses, rather than a broad based recovery in underlying construction demand.

Revenue of $NZ5.994 billion from continuing operations increased 7.3 per cent in full year 2026 when compared to the prior corresponding period.

Total net earnings attributable to shareholders reached $NZ228 million, compared to a loss of $NZ419 million in the prior year.

The return to profitability improves the balance sheet and reduces financial risk. But, in my view, a continuing recovery remains heavily dependent on building markets returning to normal in what I consider a most challenging underlying environment.

The post Buy, hold, sell: Generation Development, Fletcher Building, Saluda Medical shares appeared first on The Motley Fool Australia.

More reading

• Expert names 2 beaten-down ASX All Ords healthcare shares to buy today
• Here are the top 10 ASX 200 shares today
• Could this ASX healthcare stock really be set to rise 400%? Morgans thinks so 
• Top 3 beaten-down ASX 200 shares from August worth a second look
• The five worst-performing ASX 200 shares in August unmasked

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Generation Development Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

At the start of 2026, Ramsay Health Care Ltd (ASX: RHC) was hardly the kind of stock investors were chasing.

Fast-forward 8 months, and the picture looks very different.

Ramsay shares are up another 1.52% to $54.11 on Thursday, taking the private hospital operator to its highest level in several years.

The stock has now surged around 57% in 2026 and sits almost 80% above its 52-week low of $30.39.

It was changing hands at just $44.02 on 26 August. Since then, the share price has jumped almost 23% in a little over 2 weeks.

After years of going nowhere, Ramsay has suddenly become one of the more interesting turnaround stories on the ASX.

And I think its latest results explain a lot of the recent excitement.

The numbers are finally improving

Ramsay’s FY26 result was a pretty decent one.

Revenue came in at $18.6 billion, while underlying EBIT rose 11.8% to around $1.16 billion.

Underlying net profit after tax (NPAT) increased 19.3% to $364.1 million, or 22.9% on a constant currency basis.

Australia did much of the work, helped by higher hospital activity, better theatre utilisation, improved private health insurance pricing, and tighter cost control.

The group’s underlying EBIT margin also improved by 30 basis points to 6.2%.

Shareholders got a little extra too, with the full-year dividend rising 13.8% to 91 cents per share.

The business could look very different

Ramsay is moving ahead with plans to separate its 52.79% stake in Ramsay Santé, which owns hospitals across Europe.

Shareholders are expected to vote on the proposed demerger in November.

If the deal goes ahead, investors would be left with a simpler Ramsay business and a much clearer view of how its Australian hospitals are performing.

Ramsay is still putting money into Australia too, with the company agreeing to buy National Capital Private Hospital in Canberra for $251 million.

Management expects the acquisition to add to earnings in its first 12 months.

Would I buy Ramsay shares?

This is probably where I would be a little more careful.

At $54.11, Ramsay shares have already moved above the average TipRanks analyst price target of $50.66. The highest target is $55.69.

Director Michael Siddle also sold 1 million shares at $49 shortly after the result, in an off-market transaction worth $49 million.

Yes, I still like what I am seeing from the business, and I think the turnaround has more substance behind it.

But I wouldn’t be chasing Ramsay shares purely because they have been going up.

The post Up 57% this year. Guess which ASX 200 stock just hit a multi-year high? appeared first on The Motley Fool Australia.

More reading

• CSL led the ASX healthcare shares rebound. Can it continue?
• Top 3 ASX healthcare shares to buy after a brutal year
• Own BHP, Woodside or Coles shares? Here’s what investors should know
• 5 things to watch on the ASX 200 on Thursday
• Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Zip Co Ltd (ASX: ZIP) shares have crashed another 4% in Thursday lunchtime trade, to $2.20 a piece.

Today’s sell-off follows a long run of declines, reversing any gains made during a brief recovery in June and July. The shares are now down 11% this week, and have shed just over 22% over the past month alone.

The shares are now also around 52% lower than 12 months ago.

What is going on with Zip shares this week?

There hasn’t been any price-sensitive news out of Zip this week to explain the latest sell-off.

The buy now, pay later (BNPL) provider’s shares have been very volatile throughout 2026 so far, swinging anywhere between $3.56 in January, and a low of $1.38 in March. 

Most recently, the sell-off picked up pace after the company posted its FY26 results on the 20th of August. 

Zip posted a record result, including a huge 57.9% increase in its cash EBTDA, a 24.7% increase in total revenue, and a 45.7% hike in its NPAT for FY26.

The company also said it expects its cash EBTDA to climb even higher in FY27, by around 26% thanks to strong growth and greater scale across the business.

The announcement was initially well received by investors, who rushed to snap up the BNPL provider’s shares. But gains were quickly reversed and the shares are now down around 28% since the announcement.

While the result itself was positive, it looks like many investors were underwhelmed by the company’s expectations for future growth.

Zip said it is aiming to deliver a group cash EBTDA of $340 million in FY27, up 26% on FY26, and target an operating margin of 20% to 22%. That’s much lower than the 57.9% cash EBTDA growth the company experienced in FY26.

The news also came against a backdrop of volatile markets and weak investor sentiment, adding further pressure to the share price.

Now the question is, is the latest sell-off a buying opportunity to buy the ASX tech shares for cheap, or is there more downside coming?

Here’s what the experts think.

What’s ahead for the ASX tech stock?

Analysts are incredibly bullish on Zip shares, with widespread anticipation that we’ll see a significant upside over the next 12 months.

Market Index data shows all brokers agree on a strong buy rating, and the $3.95 target price implies around a 78% upside, at the time of writing.

TradingView data shows something similar. All 12 analysts have a buy/strong buy rating on the shares. The average $4.56 target price implies a potential 106% upside ahead, at the time of writing. Although some are confident that Zip shares can climb another 171% to $6.03 over the next 12 months.

UBS recently confirmed its buy rating and $4.70 target price on Zip shares. The broker said that the outlook for the current year was better than expected, providing comfort around the defensive qualities of the buy now, pay later business model through slowing economic times.

The team at Macquarie also agrees. The broker has a buy rating and $3.50 target price on the shares. Macquarie said “Zip’s outlook remains attractive as management executes the market opportunity in the US, supported by performance in AU”.

The post Zip shares crash another 11% this week: What is going on? appeared first on The Motley Fool Australia.

More reading

• 3 ASX growth shares experts think could double
• Can Zip shares recover? Here’s what the experts have to say
• Experts tip battered Zip shares to deliver over 90% returns
• These are the 10 most shorted ASX shares
• ASX 200 bank shares led a financial sector rebound last week

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.